Skip to main content
[Preprint]. 2023 Apr 3:2023.03.30.23287968. [Version 1] doi: 10.1101/2023.03.30.23287968

Table 1:

Statistical validation of MR results. The table shows the results of heterogeneity and pleiotropy tests performed for all biomarkers that had significant association with subcortical volume. Table 1A shows the results for proteins and 1B shows the results for the metabolites. Q refers to Cochran’s Q estimate for the heterogeneity test; DF is the degree of freedom. The Int refers to the MR-Egger intercept for the pleiotropy test and SE is the standard error of the Intercept.

Biomarker ID (Exposure) Region (Outcome) Heterogeneity Test Pleiotropy test

Q Q_DF p-val Int SE p-val
(1A) Proteins

SCGB1C1.5960.49.3 Accumbens 7.12 16 0.971 −0.12 0.88 0.893
SERPING1.4479.14.2 Accumbens 43.59 35 0.151 0.12 0.63 0.852
GZMA.3440.7.2 Amygdala 21.54 26 0.714 −0.45 2.26 0.841
TMPRSS11D.6547.83.3 Caudate 58.99 46 0.095 2.85 2.78 0.311
TXNDC12.4815.25.3 Caudate 87.65 80 0.261 −2.37 1.63 0.15
C5orf38.6378.2.3 Hippocampus 41.42 43 0.540 0.11 1.82 0.952
CPNE1.5346.24.3 Hippocampus 28.60 24 0.236 1.62 2.46 0.516
CTF1.13732.79.3 Hippocampus 34.77 28 0.177 −1.97 2.60 0.454
VIMP.11286.78.3 Hippocampus 24.13 28 0.675 −0.30 2.17 0.891
ASIP.5676.54.3 Putamen 55.63 49 0.239 3.79 1.97 0.061
CTRB1.5671.1.3 Thalamus 21.99 40 0.991 1.57 2.47 0.528

(1B) Metabolites

Uridine Amygdala 11.90 21 0.942 1.1 2.26 0.634
Arachidonate Amygdala 20.25 28 0.855 0.41 1.01 0.686
Mannose Caudate 32.76 30 0.333 4.71 2.81 0.104
Urate Thalamus 23.63 27 0.650 −1.64 3.29 0.623
1-arachidonoylglycerphosphocholine Thalamus 25.42 22 0.277 −0.28 2.64 0.915
N-acetylornithine Thalamus 18.74 25 0.809 3.78 2.27 0.109